CoChat

3,6′‐Dithiothalidomide, a new TNF‐α synthesis inhibitor, attenuates the effect of Aβ1–42intracerebroventricular injection on hippocampal neurogenesis and memory deficit

Open access
Russo, Isabella, Caracciolo, Luca, Tweedie, David, Choi, Sang‐Ho, Greig, Nigel H., Barlati, Sergio, Bosetti, Francesca · 2012 · Journal of Neurochemistry
Cited by 65

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

J. Neurochem. (2012)122, 1181–1192. Evidence indicates altered neurogenesis in neurodegenerative diseases associated with inflammation, including Alzheimer’s disease (AD). Neuroinflammation and its propagation have a critical role in the degeneration of hippocampal neurons, cognitive impairment, and altered neurogenesis. Particularly, tumor necrosis factor (TNF)‐α plays a central role in initiating and regulating the cytokine cascade during an inflammatory response and is up‐regulated in brain of AD patients. In this study, we investigated the effects of a novel thalidomide‐based TNF‐α lowering drug, 3,6′‐dithiothalidomide, on hippocampal progenitor cell proliferation, neurogenesis and, memory tasks after intracerebroventricular injection of β‐amyloid (Aß)1–42 peptide. Seven days after Aβ 1–42 injection, a significant proliferation of hippocampal progenitor cells and memory impairment were evident. Four weeks after Aβ 1–42 peptide injection, elevated numbers of surviving 5‐bromo‐2′‐deoxyuridine cells and newly formed neurons were detected. Treatment with 3,6′‐dithiothalidomide attenuated these Aβ 1–42 provoked effects. Our data indicate that although treatment with 3,6′‐dithiothalidomide in part attenuated the increase in hippocampal neurogenesis caused by Aβ 1–42‐induced neuroinflammation, the drug prevented memory deficits associated with increased numbers of activated microglial cells and inflammatory response. Therefore, 3,6′‐dithiothalidomide treatment likely reduced neuronal tissue damage induced by neuroinflammation following Aβ 1–42 injection. Understanding the modulation of neurogenesis, and its relationship with memory function could open new therapeutic interventions for AD and other neurodegenerative disorders with an inflammatory component.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2012.07846.x

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 58

  1. 10.1016/S0197-4580(00)00124-X · DOI · Paper page
  2. 10.1111/j.1471-4159.2011.07377.x · DOI
  3. 10.1186/1742-2094-9-23 · DOI · Paper page
  4. 10.18632/aging.100021 · DOI · Paper page
  5. 10.1016/j.gde.2003.08.012 · DOI · Paper page
  6. 10.2174/156720511795255982 · DOI · Paper page
  7. 10.1523/JNEUROSCI.22-07-j0001.2002 · DOI · Paper page
  8. 10.1016/S0006-291X(84)80190-4 · DOI · Paper page
  9. 10.1016/S0006-8993(97)00375-2 · DOI · Paper page
  10. Greig N. H., 2004, Thalidomide‐based TNF‐alpha inhibitors for neurodegenerative diseases, Acta Neurobiol. Exp. (Wars), 64, 1, 10.55782/ane-2004-1486 · DOI
  11. 10.1016/0092-8674(95)90192-2 · DOI · Paper page
  12. 10.1073/pnas.95.2.570 · DOI · Paper page
  13. 10.1126/science.1072994 · DOI · Paper page
  14. 10.1016/j.expneurol.2005.07.024 · DOI
  15. 10.1111/j.1749-6632.2003.tb07478.x · DOI · Paper page
  16. 10.2174/138161208784480171 · DOI · Paper page
  17. 10.1523/JNEUROSCI.2723-06.2006 · DOI · Paper page
  18. 10.1016/j.bbr.2004.04.012 · DOI · Paper page
  19. 10.1073/pnas.0403678101 · DOI · Paper page
  20. 10.1242/dev.00203 · DOI · Paper page
  21. 10.1016/j.preteyeres.2010.08.003 · DOI
  22. 10.1016/j.cbi.2011.10.001 · DOI
  23. 10.1016/j.expneurol.2009.08.009 · DOI · Paper page
  24. 10.1046/j.1471-4159.1999.0722479.x · DOI · Paper page
  25. 10.1523/JNEUROSCI.4580-03.2004 · DOI · Paper page
  26. 10.1016/S0198-8859(98)00056-1 · DOI
  27. 10.1074/jbc.M311766200 · DOI · Paper page
  28. 10.2174/156720510790691362 · DOI · Paper page
  29. 10.1016/j.nbd.2009.01.006 · DOI · Paper page
  30. 10.1093/toxsci/kfs004 · DOI · Paper page
  31. 10.1084/jem.177.6.1675 · DOI · Paper page
  32. 10.1016/0006-8993(96)00273-9 · DOI · Paper page
  33. 10.1038/mt.2008.163 · DOI
  34. PaxinosG.andFranklinK. B. J.(eds) (2001)The mouse brain in stereotaxic coordinates. San Diego CA:Academic Press.
  35. 10.1016/S0197-4580(01)00291-3 · DOI · Paper page
  36. 10.1038/6368 · DOI · Paper page
  37. 10.1016/j.bbr.2006.11.032 · DOI
  38. 10.1111/j.1471-4159.2010.07168.x · DOI · Paper page
  39. 10.4161/cc.10.15.15946 · DOI
  40. 10.1084/jem.173.3.699 · DOI · Paper page
  41. 10.1038/nm1782 · DOI · Paper page
  42. 10.1002/hipo.20845 · DOI · Paper page
  43. Sutton E. T., 1999, Amyloid‐beta peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin‐1, J. Submicrosc. Cytol. Pathol., 31, 313
  44. 10.1016/j.brainres.2009.05.035 · DOI
  45. 10.1186/gb-2007-8-1-r14 · DOI
  46. 10.1073/pnas.0914613107 · DOI · Paper page
  47. 10.2174/156720507781788873 · DOI · Paper page
  48. 10.1016/j.jneumeth.2009.06.034 · DOI
  49. 10.1186/1742-2094-9-106 · DOI · Paper page
  50. 10.1038/nrd2075 · DOI · Paper page
  51. 10.1523/JNEUROSCI.5564-06.2007 · DOI · Paper page
  52. 10.1038/sj.cdd.4401189 · DOI · Paper page
  53. 10.1016/S0163-7258(00)00081-4 · DOI · Paper page
  54. 10.1016/j.bbr.2005.03.026 · DOI
  55. 10.1038/sj.bjp.0704047 · DOI · Paper page
  56. 10.1523/JNEUROSCI.22-08-03025.2002 · DOI · Paper page
  57. 10.1111/j.1749-6632.2000.tb05555.x · DOI · Paper page
  58. 10.1021/jm030152f · DOI

Cited by

See all 65

Metadata

Authors
Russo, I., Caracciolo, L., Tweedie, D., Choi, S., Greig, N. H., Barlati, S., & Bosetti, F.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2012-07-25
Volume
122
Issue
6
Pages
1181-1192
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W1622028638
Cited by
65
References
15
FWCI
2.11
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.